Figure 1From: Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis Observed and predicted incidence of invasive cervical cancer in the UK. UK statistics. Cancer registration in England, 2002.Back to article page